Katarzyna Rygiel, M.D.; Revocation of Registration, 28580 [05-9837]

Download as PDF 28580 Federal Register / Vol. 70, No. 95 / Wednesday, May 18, 2005 / Notices DEA does not have statutory authority under the Controlled Substances Act to issue or maintain a registration if the applicant or registrant is without state authority to handle controlled substances in the state in which he conducts business. See 21 U.S.C. 802(21), 823(f) and 824(a)(3). this prerequisite has been consistently upheld. See Stephen J. Graham, M.D., 69 FR 11,661 (2004); Dominick A. Ricci, M.D., 58 FR 51104 (1993); Bobby Watts, M.D., 53 FR 11,919 (1988). Revocation is also appropriate when a State license has been suspended, but with possibility of future reinstatement. See Alton E. Ingram, Jr., M.D., 69 FR 22,562 (2004); Ann Lazar Thorn, M.D., 62 FR 847 (1997) Here, it is clear Dr. Goobermen is not currently licensed to handle controlled substances in Pennsylvania, where he seeks registration with DEA. Therefore, he is not entitled to such a registration. Accordingly, the Deputy Administrator of the Drug Enforcement Administration, pursuant to the authority vested in her by 21 U.S.C. 823 and 824 and 28 CFR 0.100(b) and 0.104, hereby orders that the pending application of Lance L. Gooberman, M.D., for registration be, and it hereby is, denied. This order is effective June 17, 2005. Dated: May 9, 2005. Michele M. Leonhart, Deputy Administrator. [FR Doc. 05–9834 Filed 5–17–05; 8:45 am] BILLING CODE 4410–09–M DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. 05–01] Katarzyna Rygiel, M.D.; Revocation of Registration On September 3, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Katarzyna Rygiel, M.D. (Dr. Rygiel) of San Diego, California, notifying her of an opportunity to show cause as to why DEA should not revoke her DEA Certificate of Registration BK4222179, as a practitioner, pursuant to 21 U.S.C. 824(a)(3) and deny any pending applications for renewal of that registration pursuant to 21 U.S.C. 823(f). As the basis for revocation, the Order to Show Cause alleged that Dr. Rygiel’s license to practice medicine in California had been revoked and accordingly, she was not authorized to VerDate jul<14>2003 14:03 May 17, 2005 Jkt 205001 handle controlled substances in California, the state in which she is registered. In a letter dated October 6, 2004, through her counsel, Dr. Rygiel timely requested a hearing in this matter. In that letter she admitted the California Medical Board had revoked her license but argued that decision was being reviewed by the Superior Court of California, County of San Diego. On October 13, 2004, the government filed a Motion for Summary Disposition, requesting that Administrative Law Judge Gail A. Randall (Judge Randall) summarily dismiss the action, arguing that Dr. Rygiel lacked state authority to handle controlled substances in California. On October 14, 2004, Judge Randall issued an Order staying proceedings and affording Dr. Rygiel an opportunity to respond to the Government’s motion. Dr. Rygiel then filed a Motion for Further Stay of Proceedings and Opposition to Government’s Motion for Summary Adjudication and Alternatively, Motion for Stay of Judgment (Response). In that Response Dr. Rygiel acknowledged she was currently without state authority to practice medicine in California but argued the DEA hearing should be stayed until the San Diego Superior Court had issued an anticipated decision in her favor. On November 22, 2004, Judge Randall issued her Order, Opinion and Recommended Decision of the Administrative Law Judge (Opinion and Recommended Decision). As part of her recommended ruling, Judge Randall granted the Government’s Motion for Summary Disposition, finding Dr. Rygiel lacked authorization to handle controlled substances in California, the jurisdiction in which she is registered. Judge Randall recommended that Dr. Rygiel’s DEA registration be revoked. No exceptions were filed by either party to the Opinion and Recommended Decision and on January 11, 2005, the record of these proceedings was transmitted to the Office of the DEA Deputy Administrator. The Deputy Administrator has considered the record in its entirety and pursuant to 21 CFR 1316.67, hereby issues her final order based upon findings of fact and conclusions of law as hereinafter set forth. The Deputy Administrator adopts, in full, the Opinion and Recommended Decision of the Administrative Law Judge. The Deputy Administrator finds that Dr. Rygiel holds DEA Certificate of Registration, BK4222179. The Deputy Administrator further finds that on March 16, 2004, the Division of Medical Quality, Medical Board of California, PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 Department of Consumer Affairs, State of California (Board) issued a Decision revoking Dr. Rygiel’s Physician and Surgeon’s Certificate. In that Decision, the Board adopted a February 13, 2004, Proposed Decision of a California Administrative Law Judge which recommended revocation of Dr. Rygiel’s medical license on certain enumerated grounds. There is no evidence in the record indicating the Board’s Decision has been stayed or set aside by judicial action, rescinded by the Board or that Dr. Rygiel’s license has been reinstated. Therefore, the Deputy Administrator finds that Dr. Rygiel is currently not licensed to practice medicine in California and, as a result, it is reasonable to infer that she is also without authorization to handle controlled substances in that state. DEA does not have statutory authority under the Controlled Substances Act to issue or maintain a registration if the applicant or registrant is without state authority to handle controlled substances in the state in which she conducts business. See 21 U.S.C. 802(21), 823(f) and 824(a)(3). This prerequisite has been consistently upheld. See Gabriel Sagun Orzame, M.D., 69 FR 58959 (2004); Dominick A. Ricci, M.D., 58 FR 51104 (1993); Bobby Watts, M.D., 53 FR 11919 (1988). Here, it is clear that Dr. Rygiel is not currently authorized to handle controlled substances in California, where she is registered with DEA. Therefore, she is not entitled to maintain that registration. Accordingly, the Deputy Administrator of the Drug Enforcement Administration, pursuant to the authority vested in her by 21 U.S.C. 823 and 824 and 28 CFR 0.100(b) and 0.104, hereby orders that DEA Certificate of Registration, BK4222179, issued to Katarzyna Rygiel, M.D., be, and it hereby is, revoked. The Deputy Administrator further orders that any pending applications for renewal or modification of such registration be, and they hereby are, denied. This order is effective June 17, 2005. Dated: May 9, 2005. Michele M. Leonhart, Deputy Administrator. [FR Doc. 05–9837 Filed 5–17–05; 8:45 am] BILLING CODE 4410–09–M DEPARTMENT OF JUSTICE Drug Enforcement Administration Rebecca Sotelo Denial of Registration On October 6, 2004, the Deputy Assistant Administrator, Office of E:\FR\FM\18MYN1.SGM 18MYN1

Agencies

[Federal Register Volume 70, Number 95 (Wednesday, May 18, 2005)]
[Notices]
[Page 28580]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9837]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. 05-01]


Katarzyna Rygiel, M.D.; Revocation of Registration

    On September 3, 2004, the Deputy Assistant Administrator, Office of 
Diversion Control, Drug Enforcement Administration (DEA), issued an 
Order to Show Cause to Katarzyna Rygiel, M.D. (Dr. Rygiel) of San 
Diego, California, notifying her of an opportunity to show cause as to 
why DEA should not revoke her DEA Certificate of Registration 
BK4222179, as a practitioner, pursuant to 21 U.S.C. 824(a)(3) and deny 
any pending applications for renewal of that registration pursuant to 
21 U.S.C. 823(f). As the basis for revocation, the Order to Show Cause 
alleged that Dr. Rygiel's license to practice medicine in California 
had been revoked and accordingly, she was not authorized to handle 
controlled substances in California, the state in which she is 
registered.
    In a letter dated October 6, 2004, through her counsel, Dr. Rygiel 
timely requested a hearing in this matter. In that letter she admitted 
the California Medical Board had revoked her license but argued that 
decision was being reviewed by the Superior Court of California, County 
of San Diego.
    On October 13, 2004, the government filed a Motion for Summary 
Disposition, requesting that Administrative Law Judge Gail A. Randall 
(Judge Randall) summarily dismiss the action, arguing that Dr. Rygiel 
lacked state authority to handle controlled substances in California. 
On October 14, 2004, Judge Randall issued an Order staying proceedings 
and affording Dr. Rygiel an opportunity to respond to the Government's 
motion. Dr. Rygiel then filed a Motion for Further Stay of Proceedings 
and Opposition to Government's Motion for Summary Adjudication and 
Alternatively, Motion for Stay of Judgment (Response). In that Response 
Dr. Rygiel acknowledged she was currently without state authority to 
practice medicine in California but argued the DEA hearing should be 
stayed until the San Diego Superior Court had issued an anticipated 
decision in her favor.
    On November 22, 2004, Judge Randall issued her Order, Opinion and 
Recommended Decision of the Administrative Law Judge (Opinion and 
Recommended Decision). As part of her recommended ruling, Judge Randall 
granted the Government's Motion for Summary Disposition, finding Dr. 
Rygiel lacked authorization to handle controlled substances in 
California, the jurisdiction in which she is registered. Judge Randall 
recommended that Dr. Rygiel's DEA registration be revoked. No 
exceptions were filed by either party to the Opinion and Recommended 
Decision and on January 11, 2005, the record of these proceedings was 
transmitted to the Office of the DEA Deputy Administrator.
    The Deputy Administrator has considered the record in its entirety 
and pursuant to 21 CFR 1316.67, hereby issues her final order based 
upon findings of fact and conclusions of law as hereinafter set forth. 
The Deputy Administrator adopts, in full, the Opinion and Recommended 
Decision of the Administrative Law Judge.
    The Deputy Administrator finds that Dr. Rygiel holds DEA 
Certificate of Registration, BK4222179. The Deputy Administrator 
further finds that on March 16, 2004, the Division of Medical Quality, 
Medical Board of California, Department of Consumer Affairs, State of 
California (Board) issued a Decision revoking Dr. Rygiel's Physician 
and Surgeon's Certificate. In that Decision, the Board adopted a 
February 13, 2004, Proposed Decision of a California Administrative Law 
Judge which recommended revocation of Dr. Rygiel's medical license on 
certain enumerated grounds.
    There is no evidence in the record indicating the Board's Decision 
has been stayed or set aside by judicial action, rescinded by the Board 
or that Dr. Rygiel's license has been reinstated. Therefore, the Deputy 
Administrator finds that Dr. Rygiel is currently not licensed to 
practice medicine in California and, as a result, it is reasonable to 
infer that she is also without authorization to handle controlled 
substances in that state.
    DEA does not have statutory authority under the Controlled 
Substances Act to issue or maintain a registration if the applicant or 
registrant is without state authority to handle controlled substances 
in the state in which she conducts business. See 21 U.S.C. 802(21), 
823(f) and 824(a)(3). This prerequisite has been consistently upheld. 
See Gabriel Sagun Orzame, M.D., 69 FR 58959 (2004); Dominick A. Ricci, 
M.D., 58 FR 51104 (1993); Bobby Watts, M.D., 53 FR 11919 (1988).
    Here, it is clear that Dr. Rygiel is not currently authorized to 
handle controlled substances in California, where she is registered 
with DEA. Therefore, she is not entitled to maintain that registration. 
Accordingly, the Deputy Administrator of the Drug Enforcement 
Administration, pursuant to the authority vested in her by 21 U.S.C. 
823 and 824 and 28 CFR 0.100(b) and 0.104, hereby orders that DEA 
Certificate of Registration, BK4222179, issued to Katarzyna Rygiel, 
M.D., be, and it hereby is, revoked. The Deputy Administrator further 
orders that any pending applications for renewal or modification of 
such registration be, and they hereby are, denied. This order is 
effective June 17, 2005.

    Dated: May 9, 2005.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. 05-9837 Filed 5-17-05; 8:45 am]
BILLING CODE 4410-09-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.